Abstract:BackgroundHelicobacter pylori (H. pylori) infection is associated with the development of gastric cancer, although the mechanism is unclear. Herein, this study aimed to clarify the key genes and signaling pathways involved in H. pylori pathogenesis based on The Cancer Genome Atlas (TCGA) database and RNA sequencing analysis. Materials and MethodsForty-nine gastric cancer samples (16 with H. pylori and 33 without H. pylori) and 35 cancer-adjacent normal samples from TCGA database were analyzed by bioinformatics. The differentially expressed genes between H. pylori-positive and H. pylori-negative patients were verified in 18 gastric cancer (GC) samples (9 with H. pylori and 9 without H. pylori), which were analyzed using RNA sequencing. Survival analysis was carried out to explore associations between the differentially expressed genes and prognosis. Bioinformatics analysis was performed to determine the signaling pathways associated with H. pylori. ResultsThe baseline level of clinical features from TCGA database and RNA sequencing showed no differences between the H. pylori-positive and H. pylori-negative GC groups (P>0.05). TP53 was shown to be upregulated in the H. pylori-positive group in both TCGA database and RNA sequencing data, which also showed higher expression in the GC tissues than in adjacent normal tissues (P<0.05). CCDC151, CHRNB2, GMPR2, HDGFRP2, and VSTM2L were shown to be downregulated in the H. pylori-positive group by both TCGA database and RNA sequencing, which also showed lower expression in the GC tissues than in adjacent normal tissues (P<0.05). GC patients with low expression levels of HDGFRP2 had a poor prognosis (P<0.05). Thirty-three signaling pathways and 10 biological processes were found to be positively associated with H. pylori infection (P<0.05, FDR<0.05). ConclusionsThese results indicate that some genes (TP53, CCDC151, CHRNB2, GMPR2, HDGFRP2, VSTM2L) and previously unidentified signaling pathways (eg, the Hippo signaling pathway) might play an important role in H. pylori-associated GC.

Effects and mechanisms of Helicobacter pylori infection on the occurrence of extra-gastric tumors

Gastric Microbiota in Gastric Cancer and Precancerous Stages: Mechanisms of Carcinogenesis and Clinical Value

Role of the Gastric Microbiome in Gastric Cancer: from Carcinogenesis to Treatment

Effects and mechanisms of Helicobacter pylori on cancers development and immunotherapy

Helicobacter pylori and Gastrointestinal Cancers: Recent Advances and Controversies

Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum

Effects of Helicobacter Pylori on Tumor Microenvironment and Immunotherapy Responses

Effects of Helicobacter pylori infection on intestinal microbiota, immunity and colorectal cancer risk

Helicobacter pylori and unignorable extragastric diseases: Mechanism and implications

Helicobacter Pyloriinfection and Esophageal Cancer Risk: an Updated Meta-Analysis

Advances in Helicobacter pylori infection involved in gastric cancer metastasis

Clinical effects of Helicobacter pylori outside the stomach

Host pathogen interactions in Helicobacter pylori related gastric cancer

Helicobacter pylori regulates stomach diseases by activating cell pathways and DNA methylation of host cells

Effect of <i>Helicobacter pylori</i> on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer

Helicobacter and gastric malignancies

Analysis of Key Genes and Signaling Pathways Involved in Helicobacter Pylori-Associated Gastric Cancer Based on the Cancer Genome Atlas Database and RNA Sequencing Data.

[Research Progress of Helicobacter pylori-Associated Extragastric Diseases]

Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment

Reactive oxygen species and gastric carcinogenesis: The complex interaction between Helicobacter pylori and host

Molecular Mechanisms and Treatment Strategies for Helicobacter pylori-Induced Gastric Carcinogenesis and Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma